Novartis has announced plans to construct a new US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida.
MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback